You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 26, 2024

Litigation Details for Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)


✉ Email this page to a colleague

« Back to Dashboard


Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

Docket ⤷  Sign Up Date Filed 2017-03-03
Court District Court, D. Delaware Date Terminated 2019-03-18
Cause 35:271 Patent Infringement Assigned To Joseph F. Bataillon
Jury Demand None Referred To Sherry R. Fallon
Parties TEVA PHARMACEUTICALS USA, INC.
Patents 6,235,004; 6,268,343; 8,114,833; 8,846,618; 9,265,893; 9,968,659; RE41,956
Attorneys Brian P. Egan; Gregory Springsted
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .
Biologic Drugs cited in Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc.

The biologic drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .

Details for Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2017-03-02 1 Complaint United States Patent Nos. 6,268,343 (the “ʼ343 patent”), 8,114,833 (the “ʼ833 patent”), 8,846,618 (the… COUNT FOR INFRINGEMENT OF U.S. PATENT NO. 6,268,343 19. Novo Nordisk re-alleges…(the “ʼ618 patent”), 9,265,893 (the “ʼ893 patent”), and RE41,956 (the “RE ʼ956 patent”), which cover,… 1. This is an action for patent infringement under the patent laws of the United States, Title… THE PATENTS-IN-SUIT 5. On July 31, 2001, the United States Patent and Trademark External link to document
2019-03-18 101 Judgment - Consent event that the claims of U.S. Patent Nos. 6,268,343 (the "'343 patent"), 8,114,833 (the &#…'"833 patent"), 8,846,618 (the '"618 patent"), 9,265,893 (the "'…#x27;893 patent"), , and RE41,956 (the "RE '956 patent"} asserted against Teva, are…enjoined until expiration of US Patent 9,968,659 ("the '659 patent") and the '343, &…x27;833, '618, '893, and RE '956 Patents would be infringed by any unlicensed manufacture External link to document
2019-03-18 104 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,268,343 81; 8,114,833 82; 8,846,618…2017 18 March 2019 1:17-cv-00227 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.